Welcome to Markets Desk, here's what's moving the needle right now.
Anthropic has overtaken OpenAI as the most valuable private AI company in the world, closing a sixty-five billion dollar fundraise that pushes its valuation to nine hundred sixty-five billion dollars. Alongside the capital raise, the company dropped Opus four point eight, its latest general-purpose model, with a more powerful system called Mythos still in the pipeline. Both firms are now eyeing public listings.
Staying in the AI space, Nvidia is making a significant bet on photonics, a technology that transfers data using light rather than electricity. The efficiency gains could be substantial given the enormous energy demands of modern AI infrastructure, and Nvidia's investment signals this may shift how the entire industry moves data at scale.
On the pharmaceutical side, AstraZeneca received FDA approval for its immunotherapy IMFINZI in combination with BCG therapy for non-muscle-invasive bladder cancer in adults. This is a meaningful label expansion for durvalumab, adding a high-volume oncology indication and reinforcing AstraZeneca's position in immuno-oncology at a time when the pipeline is under close investor scrutiny.
That's the tape. Markets Desk, signing off the floor.
